Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company advancing innovative treatments for ...

The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services ...

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States ...

Oragenics (NYSE American: OGEN) announced that its board has approved a 1-for-30 reverse stock split of its common shares, effective June 3, 2025. Th ...

The German billionaire Christian Angermayer covers his Manhattan penthouse with symbols of his favorite investments. On one ...

But behind the American Bitcoin story is a holding company that that bets early on the key trends from bitcoin to ...

The APA Formalized the February 2024 BioVaxys Acquisition of the Former IMV Inc. Assets VANCOUVER, BC, May 29, 2025 /PRNewswire/ ...

The Road Ahead From Singapore to Frankfurt, Leo International is building more than a business — it is building a bridge ...

Biotech company Caris Life Sciences filed its paperwork to go public in the U.S. on Friday as the stock market shows signs of recovery after tariff shocks. Irving, Texas-based firm reported a revenue ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces a proposed consolidation of the ...

Detailed price information for Mind Medicine Mindmed Inc (MNMD-Q) from The Globe and Mail including charting and trades.